2021 KyPQC Fall Meeting

2021 KyPQC Recordings - IL Perinatal Quality Collaborative: Mothers and Newborns affected by Opioids

Activity Details
  • Credit Amounts:
    • CME: 1.00
    • CNE: 1.00
  • Cost: Free
  • Release: Oct 20, 2021
  • Expires: Oct 20, 2024
  • Estimated Time to Complete:
    1 Hour(s)
  • Average User Rating:
    ( Ratings)

This is a recording from the live 3rd Annual KyPQC Conference, dated October 20-21, 2021. If you claimed credit for this session at the live meeting, you should not claim credit for this module. 


Ann E.  Borders Ann E. Borders, MD, MSc, MPH
Executive Director and Obstetric Lead
Illinois Perinatal Quality Collaborative
Clinical Associate Professor
University of Chicago Pritzker School of Medicine
Maternal Fetal Medicine
NorthShore University HealthSystem, Obstetrics and Gynecology/Maternal Fetal Medicine
NorthShore University HealthSystem
Evanston Hospital
Evanston, Illinois

Needs Statement

ILPQC works closely with the Illinois Department of Public Health Regionalized Perinatal System, state health agencies, associations, and advocacy groups to improve obstetric and neonatal care to reduce maternal and infant morbidity and mortality.

With the opioid crisis continuing & worsening, it is essential for every hospital to identify pregnant patients with OUD and provide optimal OUD care for every patient, every time, to save lives. 

Target Audience

Healthcare professionals interested in successful quality improvement initiatives that could be implemented in delivery hospitals.


Upon completion of this activity, participants will be able to:
1. Review the background on opioid epidemic and implications for perinatal care
2. Discuss the MNO aims, key strategies and resources
3. Describe the MNO-OB progress and data review


In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This enduring material is designated for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.00 nursing contact hour.

Faculty Disclosure

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.

None of the planners, faculty, and others in control of educational content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.


KyPQC is Supported by Cooperative Agreement number 2 NU17CE924971, funded by the Centers for Disease Control and Prevention (CDC).